Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingfei Wang

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Cancer Research|July 10, 2012
Concomitant targeting of tumor cells and induction of T-cell response synergizes to effectively inhibit trastuzumab-resistant breast cancerQingfei Wang, Shau-Hsuan Li, Hai Wang, et al.
British Journal of Clinical Pharmacology|September 16, 2025
Clinical study of the pharmacokinetics and pharmacodynamics of Xininurad tablets in patients with renal impairmentXiaoni Wang, Yunqiu Xie, Xu Zhu, et al.
Cancer Cell|September 13, 2011
BikDD eliminates breast cancer initiating cells and synergizes with lapatinib for breast cancer treatmentJing-Yu Lang, Jennifer L Hsu, Funda Meric-Bernstam, et al.
Nature Communications|April 13, 2023
Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancerBhavana Palakurthi, Shaneann R Fross, Ian H Guldner, et al.
JCI Insight|August 8, 2020
Selective inhibition of mTORC1 in tumor vessels increases antitumor immunityShan Wang, Ariel Raybuck, Eileen Shiuan, et al.
Cell Research|March 29, 2014
Biomarker-guided sequential targeted therapies to overcome therapy resistance in rapidly evolving highly aggressive mammary tumorsOzgur Sahin, Qingfei Wang, Samuel W Brady, et al.
Cancer Research|November 8, 2013
14-3-3ζ orchestrates mammary tumor onset and progression via miR-221-mediated cell proliferationSumaiyah K Rehman, Shau-Hsuan Li, Shannon L Wyszomierski, et al.
The Journal of Clinical Investigation|December 15, 2020
Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancerDeanna N Edwards, Verra M Ngwa, Ariel L Raybuck, et al.
Cell|October 28, 2020
CNS-Native Myeloid Cells Drive Immune Suppression in the Brain Metastatic Niche through Cxcl10Ian H Guldner, Qingfei Wang, Lin Yang, et al.
Cancer Letters|February 1, 2021
In vivo selection of highly metastatic human ovarian cancer sublines reveals role for AMIGO2 in intra-peritoneal metastatic regulationYueying Liu, Jing Yang, Zonggao Shi, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Cancer Research|July 10, 2012
Concomitant targeting of tumor cells and induction of T-cell response synergizes to effectively inhibit trastuzumab-resistant breast cancerQingfei Wang, Shau-Hsuan Li, Hai Wang, et al.
British Journal of Clinical Pharmacology|September 16, 2025
Clinical study of the pharmacokinetics and pharmacodynamics of Xininurad tablets in patients with renal impairmentXiaoni Wang, Yunqiu Xie, Xu Zhu, et al.
Cancer Cell|September 13, 2011
BikDD eliminates breast cancer initiating cells and synergizes with lapatinib for breast cancer treatmentJing-Yu Lang, Jennifer L Hsu, Funda Meric-Bernstam, et al.
Nature Communications|April 13, 2023
Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancerBhavana Palakurthi, Shaneann R Fross, Ian H Guldner, et al.
JCI Insight|August 8, 2020
Selective inhibition of mTORC1 in tumor vessels increases antitumor immunityShan Wang, Ariel Raybuck, Eileen Shiuan, et al.
Cell Research|March 29, 2014
Biomarker-guided sequential targeted therapies to overcome therapy resistance in rapidly evolving highly aggressive mammary tumorsOzgur Sahin, Qingfei Wang, Samuel W Brady, et al.
Cancer Research|November 8, 2013
14-3-3ζ orchestrates mammary tumor onset and progression via miR-221-mediated cell proliferationSumaiyah K Rehman, Shau-Hsuan Li, Shannon L Wyszomierski, et al.
The Journal of Clinical Investigation|December 15, 2020
Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancerDeanna N Edwards, Verra M Ngwa, Ariel L Raybuck, et al.
Cell|October 28, 2020
CNS-Native Myeloid Cells Drive Immune Suppression in the Brain Metastatic Niche through Cxcl10Ian H Guldner, Qingfei Wang, Lin Yang, et al.
Cancer Letters|February 1, 2021
In vivo selection of highly metastatic human ovarian cancer sublines reveals role for AMIGO2 in intra-peritoneal metastatic regulationYueying Liu, Jing Yang, Zonggao Shi, et al.
Pageof 5